Drug Shortage Report for IPRAVENT
| Report ID | 186512 |
| Drug Identification Number | 02246084 |
| Brand name | IPRAVENT |
| Common or Proper name | Ipravent |
| Company Name | AA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IPRATROPIUM BROMIDE |
| Strength(s) | 42MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | NASAL NASAL |
| Packaging size | 15ML |
| ATC code | R01AX |
| ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-03-23 |
| Actual start date | |
| Estimated end date | 2023-04-26 |
| Actual end date | 2023-03-30 |
| Shortage status | Resolved |
| Updated date | 2023-03-31 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2023-03-31 | English | Compare |
| v7 | 2023-03-30 | French | Compare |
| v6 | 2023-03-30 | English | Compare |
| v5 | 2023-03-24 | English | Compare |
| v4 | 2023-03-22 | French | Compare |
| v3 | 2023-03-22 | English | Compare |
| v2 | 2023-03-08 | French | Compare |
| v1 | 2023-03-08 | English | Compare |
Showing 1 to 8 of 8